Epidemiology of the contraceptive pill and venous thromboembolism

Thrombosis Research

Volumn 127, Issue SUPPL. 3, 2011, Pages

  Hannaford, Philip C ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Combined oral contraceptives; Oestrogens; Progestogen only oral contraceptives; Progestogens; Pulmonary embolism; Review article; Venous thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; CYPROTERONE ACETATE; DESOGESTREL; DROSPIRENONE; ESTROGEN; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS MEGESTROL ACETATE; GESTODENE; LEVONORGESTREL; MESTRANOL PLUS NORETYNODREL; NORGESTIMATE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; PROTHROMBIN;

ACNE; AGE; ARTICLE; AVIATION; BLOOD CLOTTING DISORDER; CARDIOVASCULAR RISK; CHRONIC DISEASE; COMPARATIVE STUDY; DRUG CONTRAINDICATION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GENETIC DISORDER; HEART FAILURE; HIGH RISK POPULATION; HIRSUTISM; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; IMMOBILIZATION; INFECTION; INJURY; LUNG EMBOLISM; MEDICAL HISTORY; NEOPLASM; OBESITY; OVARY POLYCYSTIC DISEASE; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; RECURRENCE RISK; SCREENING TEST; VARICOSIS; VENOUS THROMBOEMBOLISM;

CONTRACEPTIVES, ORAL; CONTRACEPTIVES, ORAL, COMBINED; FEMALE; HUMANS; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 79251473687     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(11)70009-3     Document Type: Article

References (51)

1. WM Jordan Pulmonary embolism Lancet 2 1961 1146 1147
2. WHO Scientific Group on Cardiovascular Disease and Steroid Hormone Contraception Cardiovascular disease and steroid hormone contraception: report of a WHO scientific group. WHO technical report series: 877 1998 WHO Geneva, Switzerland
3. JP Vandenbroucke, T Koster, E Briët, PH Reitsma, RM Bertina, FR Rosendaal Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation Lancet 344 1994 1453 1457
4. RDT Farmer, TD Preston The risk of venous thromboembolism associated with low oestrogen oral contraceptives J Obstet Gynecol 15 1995 195 200
5. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study Lancet 346 1995 1575 1582
6. H Jick, SS Jick, V Gurewich, MW Myers, C Vasilakis Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components Lancet 346 1995 1589 1593
7. MA Lewis, LAJ Heinemann, KD MacRae, R Bruppacher, WO Spitzer, with the Transnational Research group on Oral Contraceptives and the Health of Young Women The increased risk of venous thromboembolism and use of third generation progestagens: role of bias in observational research Contraception 54 1996 5 13
8. JP Realini, CE Encarnacion, KN Chintapalli, CR Rees Oral contraceptives and venous thrombolism: a case-control study designed to minimise detection bias J Am Board Fam Pract 10 1997 315 321
9. KWM Bloemenkamp, FR Rosendaal, HR Büller, FM Heimerhorst, LP Colly, JP Vandenbroucke Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias Arch Intern Med 159 1999 65 70
10. L Parkin, DCG Skegg, M Wilson, GP Herbison, C Paul Oral contraceptives and fatal pulmonary embolism Lancet 355 2000 2133 2134
11. Ø Lidegaard, B Edström, S Kreiner Oral contraceptives and venous thromboembolism: a five-year national case-control study Contraception 65 2002 187 196 (Pubitemid 34258539)
12. S Sidney, DB Pettiti, GA Soff, DL Cundiff, KK Tolan, CP Quesenberry Venous thromboembolic disease in users of low-estrogen combined estrogenprogestin oral contraceptives Contraception 70 2004 3 10
13. C Huerta, S Johansson, M Wallander, G Rodriguez Risk factors and short term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom Arch Intern Med 167 2007 935 943
14. A Van Hylckama Vlieg, FM Helmerhorst, JP Vandenbroucke, CJM Doggen, FR Rosendaal The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study BMJ 339 2009 b2921
15. Ø Lidegaard, E Løkkegaard, AL Svendsen, C Agger Hormonal contraception and risk of venous thromboembolism: national follow-up study BMJ 339 2009 b2890
16. J Dinger, A Assmann, S Möhner, T Do Minh Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study J Fam Plann Reprod Health Care 36 2010 123 129
17. DB Pettiti, J Wingerd, F Pellegrin, S Ramcharan Oral contraceptives, smoking, and other factors in relation to risk of venous thromboembolic disease Am J Epidemiol 108 1978 480 495
18. M Thorogood, J Mann, M Murphy, M Vessey Risk factors for fatal venous thromboembolism in young women: a case-control study Int J Epidemiol 21 1992 48 52
19. WHW Inman, MP Vessey Investigation of deaths for pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age BMJ 2 1968 193 199
20. PD Stolley, JA Tonascia, MS Tockman, PE Sartwell, AH Rutledge, MP Jacobs Thrombosis with low-estrogen oral contraceptives Am J Epidemiol 102 1975 197 208
21. M Vessey, D Mant, A Smith, D Yeates Oral contraceptives and venous thromboembolism: findings in a large prospective study BMJ 292 1986 526
22. S Suissa, L Blais, WO Spitzer, J Cusson, M Lewis, L Heinneman First-time user of newer oral contraceptives and the risk of venous thromboembolism Contraception 56 1997 141 146 (Pubitemid 27450823)
23. RMC Herings, J Urquhart, HGM Leufkens Venous thromboembolism among new users of different oral contraceptives Lancet 354 1999 127 128 (Pubitemid 29313151)
24. HJ Jick, JA Kaye, C Vasilakis-Scaramozza, SS Jick Risk of venous thromboembolism among users of third generation contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis BMJ 321 2000 1190 1195
25. KWM Bloemenkamp, FR Rosendaal, FM Helmerhorst, JP Vandenbroucke Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects Arch Intern Med 160 2000 49 52
26. World Health Organization Medical eligibility criteria for contraceptive use (4th edition) http://www.who.int/reproductivehealth/publications/famil- planning/9789241563888/en/index.html [accessed 29 November 2010].
27. JP Vandenbroucke, KWM Bloemenkamp, S Middeldorp, FM Helmerhorst, BN Bouma, FR Rosendaal Oral contraceptives and the risk of venous thrombosis N Engl J Med 344 2001 1527 1535
28. J Emmerich, FR Rosendaal, M Cattaneo, V De Stefano, T Cumming, V Arruda Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism - pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism Thromb Haemost 86 2001 809 816
29. JP Vanderbroucke, FJM van der Meer, FM Helmerhorst, FR Rosendaal Factor V Leiden: should we screen oral contraceptive users and pregnant women? BMJ 313 1996 1127 1130
30. B Cosmi, C Legnani, F Bernardi, S Coccheri, G Palareti Value of family history in identifying women at risk of venous thromboembolism during oral contraception BMJ 322 2001 1024 1025 (Pubitemid 32391836)
31. I Martinelli, E Taioli, T Battaglioli, M Podda, SM Passamonti, P Pedotti Risk of venous thromboembolism after air travel. Interaction with thrombophilia and oral contraception Arch Intern Med 163 2003 2771 2774
32. SC Cannegieter, CJM Doggen, HC van Houwelingen, FR Rosendaal Travel-related venous thrombosis: results from a large population-based case control study (MEGA study) PLoS Med 3 2006 e307
33. S Kuipers, SC Cannegieter, S Middledorp, L Robyn, HR Büller, FR Rosendaal The absolute risk of venous thrombosis after air travel: a cohort study of 8,755 employees of international organisations PLoS Med 4 2007 e290
34. World Health Organization Combined hormonal contraceptive use during the postpartum period http://whqlibdoc.who.int/hq/2010/WHO-RHR-10.15-eng.pdf [accessed 8 November 2010].
35. WHW Inman, MP Vessey, B Westerholm, A Engelund Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs BMJ 2 1970 203 209
36. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease Lancet 346 1995 1582 1588
37. WO Spitzer, MA Lewis, LAJ Heinemann, M Thorogood, KD MacRae, on behalf of Transnational Research Group on Oral Contraceptives and the Health of Young Women Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study BMJ 312 1996 83 88
38. RDT Farmer, RA Lawrenson, CR Thompson, JG Kennedy, IR Hambleton Population-based study of risk of venous thromboembolism associated with various oral contraceptives Lancet 349 1997 83 88
39. SF De Bruijn, J Stam, JP Vandenbroucke Increased risk of cerebral venous sinus thrombosis with third-generation oral contraceptives. Cerebral Venous Sinus Thrombosis Study Group Lancet 351 1998 1404
40. I Martinelli, E Taioli, D Palli, PM Mannucci Risk of cerebral vein thrombosis and oral contraceptives Lancet 352 1998 326
41. P Hannaford Cardiovascular events associated with different combined oral contraceptives. A review of current data Drug Safety 22 2000 361 371
42. JM Kemmeren, A Algra, DE Grobbee Third generation oral contraceptives and risk of venous thrombosis: meta-analysis BMJ 323 2001 1 9
43. C Vasilkais-Scaramozza, H Jick Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives Lancet 358 2001 1427 1429 (Pubitemid 33055749)
44. HE Seaman, CS de Vries, RDT Farmer The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol: a nested cohort analysis and case-control study Hum Reprod 18 2003 522 526
45. RDT Farmer, RA Lawperson, JC Todd, TJ Williams, K Macrae Oral contraceptives and venous thromboembolic disease. Analyses of the UK General Practice Research Database and the UK MediPlus Database Hum Reprod Update 5 1999 688 706
46. HE Seaman, CS de Vries, RDT Farmer Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette(r)): observational studies using the UK General Practice Research Database Pharm Drug Saf 13 2004 427 436
47. JC Dinger, LAJ Heinemann, D Kühl-Habich The safety of a drospirenonecontaining oral contraceptive: final results from the European Active Surveillance study in Oral Contraceptives based on 142,475 women-years of observation Contraception 75 2007 344 354
48. JD Seeger, J Loughlin, PM Eng, CR Clifford, J Cutone, AM Walker Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives Obstet Gynecol 110 2007 587 593
49. S Shapiro, J Dinger Risk of venous thromboembolism among users of oral contraceptives: a review of two recently published studies J Fam Plann Reprod Health Care 36 2010 33 38
50. JC Todd, R Lawrenson, RDT Farmer, TJ Williams, GM Leydon Venous thromboembolic disease and combined oral contraceptives: a reanalysis of the MediPlus database Hum Reprod 14 1999 1500 1505
51. LAJ Heinemann, JC Dinger Range of published estimates of venous thromboembolism incidence in young women Contraception 75 2007 328 336